BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

621 related articles for article (PubMed ID: 28734065)

  • 1. FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder.
    Meles SK; Vadasz D; Renken RJ; Sittig-Wiegand E; Mayer G; Depboylu C; Reetz K; Overeem S; Pijpers A; Reesink FE; van Laar T; Heinen L; Teune LK; Höffken H; Luster M; Kesper K; Adriaanse SM; Booij J; Leenders KL; Oertel WH
    Mov Disord; 2017 Oct; 32(10):1482-1486. PubMed ID: 28734065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Metabolic Pattern of Idiopathic REM Sleep Behavior Disorder Reflects Early-Stage Parkinson Disease.
    Meles SK; Renken RJ; Janzen A; Vadasz D; Pagani M; Arnaldi D; Morbelli S; Nobili F; Mayer G; Leenders KL; Oertel WH;
    J Nucl Med; 2018 Sep; 59(9):1437-1444. PubMed ID: 29476004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive Olfactory Impairment and Cardiac Sympathetic Denervation in REM Sleep Behavior Disorder.
    Janzen A; Vadasz D; Booij J; Luster M; Librizzi D; Henrich MT; Timmermann L; Habibi M; Sittig E; Mayer G; Geibl F; Oertel W
    J Parkinsons Dis; 2022; 12(6):1921-1935. PubMed ID: 35754288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Four-Year Follow-up of [
    Kogan RV; Janzen A; Meles SK; Sittig E; Renken RJ; Gurvits V; Mayer G; Leenders KL; Oertel WH;
    Mov Disord; 2021 Jan; 36(1):230-235. PubMed ID: 32909650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine transporter imaging deficit predicts early transition to synucleinopathy in idiopathic rapid eye movement sleep behavior disorder.
    Iranzo A; Santamaría J; Valldeoriola F; Serradell M; Salamero M; Gaig C; Niñerola-Baizán A; Sánchez-Valle R; Lladó A; De Marzi R; Stefani A; Seppi K; Pavia J; Högl B; Poewe W; Tolosa E; Lomeña F
    Ann Neurol; 2017 Sep; 82(3):419-428. PubMed ID: 28833467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal change in dopamine transporter availability in idiopathic REM sleep behavior disorder.
    Shin JH; Lee JY; Kim YK; Shin SA; Kim H; Nam H; Jeon B
    Neurology; 2020 Dec; 95(23):e3081-e3092. PubMed ID: 32989104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT.
    Stiasny-Kolster K; Doerr Y; Möller JC; Höffken H; Behr TM; Oertel WH; Mayer G
    Brain; 2005 Jan; 128(Pt 1):126-37. PubMed ID: 15548552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine reuptake transporter-single-photon emission computed tomography and transcranial sonography as imaging markers of prediagnostic Parkinson's disease.
    Noyce AJ; Dickson J; Rees RN; Bestwick JP; Isaias IU; Politis M; Giovannoni G; Warner TT; Lees AJ; Schrag A
    Mov Disord; 2018 Mar; 33(3):478-482. PubMed ID: 29380907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid Eye Movement Sleep Behavior Disorder: Abnormal Cardiac Image and Progressive Abnormal Metabolic Brain Pattern.
    Janzen A; Kogan RV; Meles SK; Sittig E; Renken RJ; Geibl FF; Booij J; Stormezand G; Luster M; Mayer G; Leenders KL; Oertel WH
    Mov Disord; 2022 Mar; 37(3):624-629. PubMed ID: 34796976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected].
    Iranzo A; Lomeña F; Stockner H; Valldeoriola F; Vilaseca I; Salamero M; Molinuevo JL; Serradell M; Duch J; Pavía J; Gallego J; Seppi K; Högl B; Tolosa E; Poewe W; Santamaria J;
    Lancet Neurol; 2010 Nov; 9(11):1070-7. PubMed ID: 20846908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic imaging and clinical predictors for phenoconversion of REM sleep behaviour disorder.
    Arnaldi D; Chincarini A; Hu MT; Sonka K; Boeve B; Miyamoto T; Puligheddu M; De Cock VC; Terzaghi M; Plazzi G; Tachibana N; Morbelli S; Rolinski M; Dusek P; Lowe V; Miyamoto M; Figorilli M; Verbizier D; Bossert I; Antelmi E; Meli R; Barber TR; Trnka J; Miyagawa T; Serra A; Pizza F; Bauckneht M; Bradley KM; Zogala D; McGowan DR; Jordan L; Manni R; Nobili F
    Brain; 2021 Feb; 144(1):278-287. PubMed ID: 33348363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffuse occipital hypometabolism on [18 F]-FDG PET scans in patients with idiopathic REM sleep behavior disorder: prodromal dementia with Lewy bodies?
    Fujishiro H; Iseki E; Murayama N; Yamamoto R; Higashi S; Kasanuki K; Suzuki M; Arai H; Sato K
    Psychogeriatrics; 2010 Sep; 10(3):144-52. PubMed ID: 20860570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's disease.
    Doppler K; Jentschke HM; Schulmeyer L; Vadasz D; Janzen A; Luster M; Höffken H; Mayer G; Brumberg J; Booij J; Musacchio T; Klebe S; Sittig-Wiegand E; Volkmann J; Sommer C; Oertel WH
    Acta Neuropathol; 2017 Apr; 133(4):535-545. PubMed ID: 28180961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced dopamine transporter binding predicts early transition to Lewy body disease in Japanese patients with idiopathic rapid eye movement sleep behavior disorder.
    Miyamoto T; Miyamoto M; Numahata K; Onoue H; Akaiwa Y; Sairenchi T
    J Neurol Sci; 2020 Jul; 414():116821. PubMed ID: 32330698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlations between dopaminergic dysfunction and abnormal metabolic network activity in REM sleep behavior disorder.
    Huang Z; Jiang C; Li L; Xu Q; Ge J; Li M; Guan Y; Wu J; Wang J; Zuo C; Yu H; Wu P
    J Cereb Blood Flow Metab; 2020 Mar; 40(3):552-562. PubMed ID: 30741074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Striatal dopamine transporter levels in patients with REM sleep behavior disorder: assessment with 123I-FP-CIT SPECT].
    Mossa EP; Niccoli Asabella A; Iuele F; Stabile Ianora AA; Giganti M; Rubini G
    Recenti Prog Med; 2012 Nov; 103(11):500-4. PubMed ID: 23096739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinson Disease-Related Brain Metabolic Patterns and Neurodegeneration in Isolated REM Sleep Behavior Disorder.
    Shin JH; Lee JY; Kim YK; Yoon EJ; Kim H; Nam H; Jeon B
    Neurology; 2021 Jul; 97(4):e378-e388. PubMed ID: 34011571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Motor Activity During REM Sleep Is Linked with Dopamine Function in Idiopathic REM Sleep Behavior Disorder and Parkinson Disease.
    Zoetmulder M; Nikolic M; Biernat H; Korbo L; Friberg L; Jennum P
    J Clin Sleep Med; 2016 Jun; 12(6):895-903. PubMed ID: 27070245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain Glucose Metabolism Heterogeneity in Idiopathic REM Sleep Behavior Disorder and in Parkinson's Disease.
    Arnaldi D; Meles SK; Giuliani A; Morbelli S; Renken RJ; Janzen A; Mayer G; Jonsson C; Oertel WH; Nobili F; Leenders KL; Pagani M;
    J Parkinsons Dis; 2019; 9(1):229-239. PubMed ID: 30741687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Derivation and Validation of a Phenoconversion-Related Pattern in Idiopathic Rapid Eye Movement Behavior Disorder.
    Mattioli P; Orso B; Liguori C; Famà F; Giorgetti L; Donniaquio A; Massa F; Giberti A; Vállez García D; Meles SK; Leenders KL; Placidi F; Spanetta M; Chiaravalloti A; Camedda R; Schillaci O; Izzi F; Mercuri NB; Pardini M; Bauckneht M; Morbelli S; Nobili F; Arnaldi D
    Mov Disord; 2023 Jan; 38(1):57-67. PubMed ID: 36190111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.